COMPANY
Armis Biopharma
NIH awards 5
- NIH award 3R44NS119085-04S1 FY2023: $29,610 awarded for that fiscal year; activity R44 (SBIR); PI NOBLITT, SCOTT; recipient as written: ARMIS BIOPHARMA, INC., FORT COLLINS, CO. Development of a novel product for skin source ↗
- NIH award 5R44NS119085-04 FY2023: $828,836 awarded for that fiscal year; activity R44 (SBIR); PI NOBLITT, SCOTT; recipient as written: ARMIS BIOPHARMA, INC., FORT COLLINS, CO. Development of a novel product for skin source ↗
- NIH award 4R44NS119085-03 FY2022: $526,918 awarded for that fiscal year; activity R44 (SBIR); PI NOBLITT, SCOTT; recipient as written: ARMIS BIOPHARMA, INC., FORT COLLINS, CO. Development of a novel product for skin source ↗
- NIH award 5R44NS119085-02 FY2021: $271,445 awarded for that fiscal year; activity R44 (SBIR); PI NOBLITT, SCOTT; recipient as written: ARMIS BIOPHARMA, INC., FORT COLLINS, CO. Development of a novel product for skin source ↗
- NIH award 1R44NS119085-01 FY2020: $423,048 awarded for that fiscal year; activity R44 (SBIR); PI NOBLITT, SCOTT; recipient as written: ARMIS BIOPHARMA, INC., FORT COLLINS, CO. Development of a novel product for skin source ↗